What your report means for the decision in front of you
Kim Lockheimer, PhD, DFM reads your report herself, against your diagnosis and treatment history, and writes back with what the result supports, what it does not, and what to raise with your oncology team.
$250. One report and one focused question. Kim confirms the scope, the fee and the delivery date before sending a secure invoice. Nothing is charged with this request.
You will never be pressured to purchase. If a review would not add value, Kim will tell you.
What you receive
A written assessment, not a summary of the report you already have. It arrives by email and is written so you can bring it to your next appointment.
A written assessment of the main finding
What the result shows, how strong the evidence behind it is, and what it does not establish.
Context from your history
How the finding fits with your diagnosis, stage, and the treatments already given, using the history you send.
Three to five questions for your oncologist
Written in plain language so they can be read aloud at your next appointment.
Gaps worth raising
Records or testing that are missing and would change how the result should be read.
Written findings usually arrive within 5 business days of an agreed scope.
Read a sample review first
A fictional example of a written review, with the question that prompted it and the questions that came out of it.
One report. One focused question.
This covers
- One biomarker or genomic report: FoundationOne, Signatera, Guardant360, Tempus, Caris, a pathology panel, or a germline result
- One question you most need answered, stated in your own words
- The treatment history you send with it, so the result is read in context rather than on its own
This does not
- A full records review across many documents, which is a larger engagement
- A treatment plan or a prescription, which belong with your oncologist
- Urgent interpretation of new or worsening symptoms
If your situation needs more than this, Kim tells you before you pay anything.
How it works
Step 1. Send the report and your question
Use the form below, or text or call Kim directly. Include the history that matters: diagnosis, stage, dates, and treatments so far.
Step 2. Kim replies with a yes or a no
Within one business day she tells you whether a review like this would help, what it covers, the fee, and the date you would have it. If it would not add value, she says so instead.
Step 3. You approve the scope, then pay
A secure invoice is sent only after you agree. Written findings follow, usually within five business days.
This review is not emergency care. For new or worsening symptoms, contact your treating team or local emergency services.
When ongoing support makes sense
- Results keep changing and each new one forces another decision
- Your care is spread across several teams and someone needs to keep the record straight
- You would rather have the same person reading each new result than start over each time
If one review answers your question, that is the right outcome. Ongoing support is offered when there is an ongoing need, not as an upsell.
See what ongoing support covers
Common questions
Is this the same as a second opinion?
No. A second opinion is a physician's judgment about your treatment. This is a scientific read of your report: what the data supports, what it does not, and what to ask your treating team. Your oncologist still makes treatment decisions.
Doesn't my oncologist already do this?
Some do. Many do not have time to read a full genomic report line by line or to track how the evidence behind a variant has changed since your report issued. If your oncologist has already answered your question in a way that satisfies you, you do not need this review.
What if I don't know what to ask?
Send the report and describe what you are facing. Kim will tell you whether there is a question worth paying to answer before you spend anything.
Can you do this outside the United States?
Yes. Reviews are delivered by email worldwide, and reports from non-US laboratories are accepted.
My report is more than a year old. Is it too late?
No. The sequencing data does not change, but the evidence behind a variant often does. Reanalysis of an existing report is usually far cheaper than repeating testing.
What does it cost?
$250 for one report and one focused question. Kim confirms the fee and the delivery date before sending an invoice.
Send your report to Kim
FoundationOne, Signatera, Tempus, Guardant360, Caris, pathology or a germline panel. Include the question you most want answered.
kim@mitotics.com | Text +1 (760) 500-1700 | Call +1 (888) 498-8650 | $250 Orientation Call